The aetiology of T1D is largely unknown, but it is thought that a genetic predisposition, environmental factors and distinctive metabolic changes are involved in the initiation, development and ...

While insulin remains essential for treating T1D, new thinking is that weight loss with GLP-1 RAs would also enable insulin dose reduction and add cardiorenal benefit in those with overweight or ...